Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.95
-0.45 (-0.75%)
Streaming Delayed Price
Updated: 1:47 PM EDT, Apr 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,762,221
Open
59.40
Bid (Size)
58.94 (200)
Ask (Size)
58.95 (300)
Prev. Close
59.39
Today's Range
58.68 - 59.70
52wk Range
42.52 - 62.89
Shares Outstanding
2,222,113,553
Dividend Yield
4.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
1 Unpopular Stock That Should Get More Attention and 2 We Question
Today 0:33 EDT
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via
StockStory
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
April 20, 2026
From
Ardelyx, Inc.
Via
GlobeNewswire
Performance
YTD
+10.3%
+10.3%
1 Month
+3.4%
+3.4%
3 Month
+8.7%
+8.7%
6 Month
+32.3%
+32.3%
1 Year
+20.4%
+20.4%
More News
Read More
2 Healthcare Stocks to Buy and 1 to Approach With Caution
↗
April 15, 2026
Via
The Motley Fool
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
April 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
April 14, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
Which Dividend Pharma Stock Should a Value Investor Choose Today?
↗
April 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap
↗
April 10, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Neurocrine Biosciences (NBIX): A New Era in Neuroscience and Endocrinology
April 07, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check
April 06, 2026
Via
MarketMinute
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
April 02, 2026
Via
StockStory
Topics
Government
Stocks
World Trade
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
3 Value Stocks Walking a Fine Line
April 02, 2026
Via
StockStory
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
Via
Finterra
Topics
Initial Public Offering
United Therapeutics Surges 14% on Groundbreaking Tyvaso Phase 3 Results for IPF
March 31, 2026
Via
MarketMinute
Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years
March 31, 2026
From
Bristol Myers Squibb
Via
Business Wire
1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
March 30, 2026
Via
StockStory
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
March 29, 2026
From
Bristol Myers Squibb
Via
Business Wire
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
March 28, 2026
From
Bristol Myers Squibb
Via
Business Wire
MarketMinute: Corcept Therapeutics (CORT) Surges 19.66% on Surprise FDA Approval and Oncology Breakthrough
March 26, 2026
Via
MarketMinute
Topics
Intellectual Property
Stocks making big moves yesterday: Robinhood, Payoneer, Micron, Limbach, and Bristol-Myers Squibb
March 26, 2026
Via
StockStory
Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way
March 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
March 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
March 25, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
↗
March 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 58.95
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 04/22/26 01:47 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 130.98B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 131B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today